Cancer Registry Software Market

Global Cancer Registry Software Market Forecast

The Cancer Registry Software Market is expected to grow from USD 245.6 Million in 2026 to USD 614.6 Million by 2033, reflecting strong industry expansion and registering a CAGR of 14.0% during the forecast period from 2026 to 2033.

The global cancer registry software market refers to the market for software solutions designed to help healthcare organizations track and manage data related to cancer cases. Cancer registry software typically includes tools for collecting, managing, analysing, and reporting cancer-related data, such as patient demographics, diagnosis, and treatment information, as well as outcomes. The market for cancer registry software is driven by the growing prevalence of cancer worldwide, as well as the increasing adoption of electronic health records (EHRs), and other digital health technologies. Cancer registry software is used by a wide range of healthcare organizations, including hospitals, clinics, research institutions, and government agencies. This market is expected to continue to grow in the coming years as healthcare organizations look to increasingly use data analytics and other advanced technologies to improve cancer prevention, diagnosis, and treatment.

• The global cancer registry software market was valued at over US$56 Mn in 2020
• The cloud-based deployment mode segment is expected to registry the highest growth rate
• Adoption will be the highest across hospitals and clinics accounts for the largest share of the market
• The Asia Pacific region is projected to index the highest growth rate over the forecast period

Greater Awareness, and the Increasing Incidence of Cancers

In recent years, there has been a steady increase in the number of individuals who are more aware of early detection and cancer screening processes owing to the highly beneficial data they offer to both patients and physicians. This has led to a spike in the number of individuals being treated for cancer, thus boosting the demand for cancer registry software solutions in the process.

Another element resulting in higher awareness is the increasing incidence of cancer worldwide. Cancer registry software helps to maintain and manage cancer patient data, making it crucial for further cancer research and treatment. Additionally, the increasing need for data analytics in the healthcare sector is also expected to profoundly influence the growth trajectory of the global cancer registry software market in the years ahead.

Technological Advancements, and Favorable Governmental Initiatives

The implementation of ongoing technological developments and advancements such as machine learning, cloud computing, and Artificial Intelligence has allowed cancer registry software to provide more comprehensive and accurate cancer data. This has led to a higher adoption of cancer registry software by healthcare providers. Moreover, an increasing number of governments are rolling out initiatives to improve cancer care and management, which are expected to boost the demand for cancer registry software solutions. For example, the National Program of Cancer Registries (NPCR) was established by the US government to collect and disseminate cancer information. Factors such as these are also expected to augment growth of the global cancer registry software market.  

Growth Challenges

Data Quality Challenges, High Costs, and Lack of Skilled Professionals

Data entry errors, missing data, and inconsistencies in coding can limit the usefulness of cancer registry data for research and treatment applications, as this affects its accuracy and completeness. Additionally, cancer registry software can be expensive, which limit its adoption, particularly for smaller healthcare organizations. Moreover, this software requires skilled professionals to manage and analyse its data. A lack of these professionals to effectively use this software could also restrict its adoption. Factors such as these are expected to a growth deterrent for players engaged in the global cancer registry software market.

North America to Remain a Regional Frontrunner

Europe is expected to account for a sizeable part of the global cancer registry software market owing to factors such as the increasing adoption of EHRs as well as a high demand for cancer data analysis. The Asia Pacific region is also expected to expand at a favorable rate over the forecast period due to the growing adoption of healthcare IT solutions and the increasing incidence of cancer.

However, North America is expected to remain the regional frontrunner in the coming years owing to the significant presence of industry players, a well-established healthcare infrastructure, and favorable initiatives that are effectively promoted by respective governments in this region.

• Elekta
• Oracle
• ONCO, Inc.
• IBM
• MCKESSON CORPORATION
• Conduent, Inc.
• Ordinate Corporation
• Volpara Health Limited
• Health Catalyst
• Rocky Mountain Cancer Data Systems (RMCDS) (University of Utah Health)

The Global Cancer Registry Software Market is Segmented as Below

Software Outlook

• Standalone
• Integrated

Deployment Model Outlook

• On-premise
• Cloud Based

Component Outlook

• Commercial
• Public

End-use Outlook

• Government & Third Party
• Private Payers
• Hospital & Medical Practice
• Pharma Biotech & Medical Device Companies
• Research Institutes

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa